{"id":30436,"date":"2020-11-11T18:40:29","date_gmt":"2020-11-11T18:40:29","guid":{"rendered":"https:\/\/amelie-project.eu\/?post_type=press-release&p=30436"},"modified":"2021-05-08T07:38:26","modified_gmt":"2021-05-08T07:38:26","slug":"eu-stotter-banebrydende-forskning-i-inkontinens-med-9-mio-euro","status":"publish","type":"press-release","link":"https:\/\/amelie-project.eu\/da\/pressemeddelelse\/eu-stotter-banebrydende-forskning-i-inkontinens-med-9-mio-euro\/","title":{"rendered":"EU st\u00f8tter banebrydende forskning i inkontinens med 9,5 mio. euro"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.6.3″ custom_margin=”0px|0px|0px|0px|false|false” custom_padding=”0px|0px|0px|0px|false|false”][et_pb_row _builder_version=”4.6.3″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” width=”100%” module_alignment=”center” custom_margin=”0px|0px|0px|0px|false|false” custom_padding=”0px|0px|0px|0px|false|false”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.6.3″ text_font=”Gotham kinda bold||||||||” text_text_color=”#000000″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”0px|0px|0px|0px|false|false” custom_padding=”0px|0px|0px|0px|false|false”]<\/p>\n

EU har bevilget 9,5 mio. euro til et banebrydende forskningsprojekt om behandling af aff\u00f8ringsinkontinens.<\/p>\n

M\u00e5let med forskningen er at bruge revolutionerende celleterapi til at finde en mulig kur mod en tilstand, som sk\u00f8nnes at ramme 67 millioner mennesker i Europa.<\/p>\n

Finansieringen g\u00e5r til et konsortium best\u00e5ende af 13 organisationer i ni lande kaldet AMELIE (Anchored Muscle cELls for IncontinencE).<\/p>\n

Projektet vil blive koordineret af UCL og ledet af Richard Day, professor i regenerativ medicinsk teknologi ved UCL.<\/p>\n

Andre partnere i Storbritannien er Queen Mary University of London, NHS Blood and Transplant og velg\u00f8renhedsorganisationen Bowel Research UK, som vil st\u00e5 i spidsen for patientinddragelsen.<\/p>\n

Forskningen vil str\u00e6kke sig over fem \u00e5r, hvor forskellige institutioner i Storbritannien, Spanien og Portugal vil have hovedansvaret for hver ny fase.<\/p>\n

Projektet vil fokusere p\u00e5 at tage patientens egne muskelceller, l\u00e6gge dem p\u00e5 specialdesignede mikrob\u00e6rere og implantere dem i den beskadigede muskel for at fremme regenerering og genoprette normal funktion.<\/p>\n

Professor Day sagde, at en s\u00e5dan regenerativ medicinsk behandling giver h\u00e5b til mange mennesker, hvis liv er alvorligt forringet af inkontinens:<\/p>\n

\u201cVi er enormt begejstrede for udsigten til AMELIE-projektet og de potentielle fordele, der kan opst\u00e5 ved den nye terapeutiske tilgang, der unders\u00f8ges.<\/p>\n

\u201cVi ser frem til at arbejde sammen med det enest\u00e5ende konsortium af akademikere, klinikere, industri og velg\u00f8renhedspartnere fra hele Europa for at udvikle vores banebrydende tilgang til regenerativ medicin til behandling af denne invaliderende tilstand.<\/p>\n

\u201cDet vil v\u00e6re en radikal og innovativ tilgang, som aldrig f\u00f8r er fors\u00f8gt i s\u00e5 stor skala.\u201d<\/p>\n

Lesley Booth MBE, direkt\u00f8r for forskning og PPI hos Bowel Research UK, sagde, at selv om tilstanden er ekstremt almindelig, bliver der ikke talt meget om den.<\/p>\n

\u201cAt leve med aff\u00f8ringsinkontinens kan v\u00e6re \u00f8del\u00e6ggende. Det er helt sikkert livsbegr\u00e6nsende. Og det faktum, at det er en tilstand, som folk ikke taler frit om, g\u00f8r det bare endnu sv\u00e6rere at leve et normalt liv,\u201d siger hun.<\/p>\n

\u201cAt finde en behandling, der virker, ville ikke bare v\u00e6re et stort medicinsk gennembrud, det ville \u00e6ndre livet for millioner af mennesker.\u201d<\/p>\n

Dette projekt har modtaget st\u00f8tte fra EU's forsknings- og innovationsprogram Horizon 2020 under tilskudsaftale nr. 874807.<\/p>\n

\n

<\/p>\n

[\/et_pb_text][et_pb_image src=”https:\/\/amelie-project.eu\/wp-content\/uploads\/2021\/01\/Picture-1.png” title_text=”Picture 1″ _builder_version=”4.6.3″ _module_preset=”default”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"

The EU has awarded \u20ac9.5m to a ground breaking research project into the treatment of faecal incontinence. The aim of the research is to use revolutionary cell therapy to find a possible cure for a condition which affects an estimated 67 million people in Europe. The funding will go to a consortium of 13 organisations across nine countries called AMELIE (Anchored Muscle cELls for IncontinencE). The project will be co-ordinated by UCL and led by Richard Day, Professor of Regenerative Medicine Technology at UCL. Other partners in the UK include Queen Mary University of London, NHS Blood and Transplant and the charity Bowel Research UK, which will take the lead in patient involvement. The research will be conducted over five years, with separate institutions in the UK, Spain and Portugal taking the lead role at each new stage. The project will focus on taking the patient\u2019s own muscle cells, loading them onto specially designed microcarriers and implanting them into the damaged muscle to promote regeneration and restore normal function. Professor Day said that such regenerative medicine therapy offers hope to many people whose lives are severely impaired by incontinence: \u201cWe are tremendously excited by the prospect of the AMELIE project […]<\/p>","protected":false},"featured_media":31025,"template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"\n

The EU has awarded \u20ac9.5m to a ground breaking research project into the treatment of faecal incontinence.<\/p>\n\n\n\n

The aim of the research is to use revolutionary cell therapy to find a possible cure for a condition which affects an estimated 67 million people in Europe. <\/p>\n\n\n\n

The funding will go to a consortium of 13 organisations across nine countries called AMELIE (Anchored Muscle cELls for IncontinencE).<\/p>\n\n\n\n

The project will be co-ordinated by UCL and led by Richard Day, Professor of Regenerative Medicine Technology at UCL.<\/p>\n\n\n\n

Other partners in the UK include Queen Mary University of London, NHS Blood and Transplant and the charity Bowel Research UK, which will take the lead in patient involvement.<\/em><\/p>\n\n\n\n

The research will be conducted over five years, with separate institutions in the UK, Spain and Portugal taking the lead role at each new stage.<\/p>\n\n\n\n

The project will focus on taking the patient\u2019s own muscle cells, loading them onto specially designed microcarriers and implanting them into the damaged muscle to promote regeneration and restore normal function.<\/p>\n\n\n\n

Professor Day said that such regenerative medicine therapy offers hope to many people whose lives are severely impaired by incontinence:<\/p>\n\n\n\n

\u201cWe are tremendously excited by the prospect of the AMELIE project and the potential benefits that may arise from the new therapeutic approach being investigated.<\/p>\n\n\n\n

\u201cWe look forward to working with the exceptional consortium of academics, clinicians, industry and charity partners from across Europe to develop our pioneering regenerative medicine approach for treating this debilitating condition.<\/p>\n\n\n\n

\u201cThis will be a radical and innovative approach never before attempted at such a scale.\u201d<\/p>\n\n\n\n

Lesley Booth MBE, Director of Research and PPI at Bowel Research UK, said that, whilst the condition is extremely common, it is not much talked about.<\/p>\n\n\n\n

\u201cThe reality of living with faecal incontinence can be devastating. It is definitely life-limiting. And the fact that it\u2019s a condition which people don\u2019t discuss freely just adds to the difficulties of leading a normal life,\u201d she said.<\/p>\n\n\n\n

\u201cFinding a therapy which works would not just be a major medical breakthrough, it would be life-changing for millions.\u201d<\/p>\n\n\n\n

This project has received funding from the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement No 874807.<\/p>\n\n\n\n

Ends<\/strong><\/p>\n\n\n\n

NOTES TO EDITORS<\/strong><\/p>\n\n\n\n

AMELIE<\/strong> (Anchored Muscle cELls for IncontinencE consortium) is made up of the following: University College London, Instituto Superior Tecnico (Portugal), Queen Mary University of London, Medical University of Graz (Austria), Aarhus University Hospital (Denmark), Rouen University Hospital (France), University Hospital Erlangen (Germany), Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (Spain), NHS Blood and Transplant (UK), Polysciences Europe GmbH (Germany), Ttopstart (Netherlands), Bowel Research (UK), Consorzio per Valutazioni Biologiche e Farmacologiche (Italy).<\/p>\n\n\n\n

Horizon 2020<\/strong> is an EU funding programme for research and innovation. It is the biggest EU Research and Innovation programme ever with nearly \u20ac80 billion of funding available over 7 years (2014 to 2020) \u2013 in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market. https:\/\/ec.europa.eu\/programmes\/horizon2020\/en\/what-horizon-2020<\/a><\/p>\n\n\n\n

This project has received funding from the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement No 874807.<\/p>\n\n\n\n

AMELIE contact:<\/strong><\/p>\n\n\n\n

Media contact:<\/strong><\/p>\n\n\n\n

\"\"<\/figure>\n","_et_gb_content_width":"","_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_links_to":"","_links_to_target":""},"categories":[51],"class_list":["post-30436","press-release","type-press-release","status-publish","has-post-thumbnail","hentry","category-press-release"],"_links":{"self":[{"href":"https:\/\/amelie-project.eu\/da\/wp-json\/wp\/v2\/press-release\/30436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amelie-project.eu\/da\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/amelie-project.eu\/da\/wp-json\/wp\/v2\/types\/press-release"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amelie-project.eu\/da\/wp-json\/wp\/v2\/media\/31025"}],"wp:attachment":[{"href":"https:\/\/amelie-project.eu\/da\/wp-json\/wp\/v2\/media?parent=30436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amelie-project.eu\/da\/wp-json\/wp\/v2\/categories?post=30436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}